JESSIE STUCKEY: Open Payments
NPI 1114571072 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 29 payments from 11 companies in 2025. Trend: 2023 $1,120 · 2024 $917 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $174 |
| Otsuka America Pharmaceutical, Inc. | 6 | $127 |
| Janssen Pharmaceuticals, Inc | 3 | $84 |
| ABBVIE INC. | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Lundbeck LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Corium, LLC | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: Auvelity, REXULTI, INVEGA SUSTENNA, VRAYLAR, CAPLYTA, HETLIOZ, Azstarys, INGREZZA.
Industry payments across AR — which companies pay providers there.
